Posts by Robert S. Bader, M.D., Dermatologist
RESTYLANE SILK EXPECTED TO BE RELEASED SOON – GALDERMA’S NEWEST FILLER TREATMENT FOR THE LIPS AND LIP LINES
Since being approved by the FDA in June 2014, cosmetic surgeons have been awaiting the release to market of Galderma’s newest product to their already extensive cosmetic line consisting of Restylane, Perlane, Dysport, and Sculptra. This variation on the “old Restylane” is smoother and is expected to flow easier being a good choice for the…
Read MoreOBAMACARE – AFFORDABLE CARE ACT — MANY UNFULFILLED PROMISES
As the dust is settling, we are finding that the affordable care act (aka “Obamacare” or ACA) has left many unable to continue care with their existing healthcare providers. The promise that one can keep their existing plan and doctors is not exactly true, leaving many scrambling to find a new doctor. The truth is…
Read MoreVIAGRA LINKED TO INCREASED MELANOMA RISK
According to an article published online April 7, 2014 in JAMA Internal Medicine, the use of sildenafil (Viagra, Pfizer) is associated with an increased risk of developing invasive malignant melanoma. Other medications used to treat erectile dysfunction, including Cialis and Levitra, were not studied as they were not approved at the time that this study…
Read MoreDRUG APPROVED FOR INOPERABLE MELANOMA
Keytruda (pembrolizumab) was finally approved for the treatment of inoperable malignant melanoma. Testing was never completed as it performed so well in the early clinical trials.
Read MoreNEW FILLER IS FDA APPROVED
JUVÉDERM VOLUMA™ XC is a hyaluronic acid filler that has been FDA approved for volume correction in the cheeks. This new product will compete with the already popular Radiesse™ and is used to give more volume to the cheeks and/or fill in hollows. It appears that this product will be priced higher than Radiesse™ and,…
Read MoreNEW MELANOMA DRUG LOOKS PROMISING FOR STAGE III AND IV MELANOMA PATIENTS
51% Of Patients Benefited In Phase II Trial. Forbes (10/30, Fortonbury) reports that in a study published in Annals of Surgical Oncology, a new cancer drug, PV-10, 51% of stage III and IV melanoma patients benefited during a phase II trial, and achieved total cancer disappearance in 26%. In addition, the response tended to be both…
Read MoreNEW PRODUCT APPROVED FOR FACIAL REDNESS – ROSACEA
The FDA has approved a new product that is the first topical treatment specifically indicated for persistent facial redness that is seen in many patients with rosacea. The topical treatment works by constricting the dilated blood vessels and lasts up to 12 hours.
Read MoreNEW STUDY SHOWS THAT POOR SLEEP HABITS MAY HAVE DIRECT IMPACT ON ONE’S SKIN
The Cleveland Plain Dealer (7/23, Townsend) reports a study that shows that people who don’t get enough sleep are more likely to have skin that ages more quickly and be less healthy.
Read MoreIS DYSPORT BETTER THAN BOTOX?
This is a commonly asked question and you will hear many different opinions on this subject. The simple unbiased answer is, if there is a real difference between the two, it is likely extremely negligible. There are several OTHER factors that affect one’s results–such as number of units used, injection technique, and the dilution used…
Read MoreCAN MELANOMA BE DETECTED BY SMELL? REALLY?
Researchers from the Monell Center found that melanoma emits an odor that is different from normal skin. A portable nanosensor was useful in detecting cancerous cells in patients. Who knows, one day Dermatologists may be throwing away their blades and using non-invasive nanosensors to detect melanoma. These findings were published online in Journal of Chromatography…
Read More